Get started
Author

Cathrin Skrabs

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
2021 · Christoph Kornauth, Tea Pemovska, et al. · Cancer Discovery · 220
Assessment of Disease Dissemination in Gastric Compared With Extragastric Mucosa-Associated Lymphoid Tissue Lymphoma Using Extensive Staging: A Single-Center Experience
2006 · Markus Raderer, Stefan Wöhrer, et al. · Journal of Clinical Oncology · 191
PDF
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
2018 · Edit Porpaczy, Sabrina Tripolt, et al. · Blood · 154
PDF
Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients
2014 · Marius E. Mayerhoefer, Georgios Karanikas, et al. · Clinical Cancer Research · 116
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response
2012 · U. Jager, M. Fridrik, et al. · Haematologica · 113
PDF
MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course
2007 · S Wöhrer, M Troch, et al. · Leukemia · 101
Autoimmune thrombocytopenia in non-Hodgkin's lymphomas
2008 · A. W. Hauswirth, C. Skrabs, et al. · Haematologica · 95
PDF
Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas
2007 · Alexander W. Hauswirth, Cathrin Skrabs, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 93
Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial
2015 · U. Jaeger, M. Trneny, et al. · Haematologica · 86
PDF
Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients
2015 · Marius E. Mayerhoefer, Georgios Karanikas, et al. · Clinical Cancer Research · 85
Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.
2002 · Martin Filipits, Ulrich Jaeger, et al. · PubMed · 82
[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results
2018 · Marius E. Mayerhoefer, Ulrich Jaeger, et al. · Investigative Radiology · 65
BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils
2017 · D. Smiljkovic, K. Blatt, et al. · Allergy · 59
PDF
Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome
2003 · I Simonitsch-Klupp, I Hauser, et al. · Leukemia · 55
Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia
2012 · Michaela Gruber, Judith Bellemare, et al. · Blood · 54
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib
2016 · L Kazianka, C Drucker, et al. · Leukemia · 43
PDF
Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge
2002 · C Skrabs, C Müller, et al. · Leukemia · 43
Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era
2021 · Edit Porpaczy, Philipp Wohlfarth, et al. · Cancers · 40
PDF
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL
2019 · Christian Schmidl, Gregory I. Vladimer, et al. · Nature Chemical Biology · 39
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)
2004 · G Mitterbauer-Hohendanner, C Mannhalter, et al. · Leukemia · 38
The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma
2023 · Nina Worel, Katharina Grabmeier-Pfistershammer, et al. · Frontiers in Immunology · 31
PDF
Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma
2016 · Philipp Wohlfarth, Alexander Carlström, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 30
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study
2015 · Ana-Iris Schiefer, Christoph Kornauth, et al. · Medicine · 30
Disappearance of antiphospholipid antibodies after anti-CD19 chimeric antigen receptor T-cell therapy of B-cell lymphoma in a patient with systemic lupus erythematosus and antiphospholipid syndrome
2024 · Eleonora Friedberg, Philipp Wohlfarth, et al. · Journal of Thrombosis and Haemostasis · 26
PDF
Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma
2014 · J. Gebhart, K. Lechner, et al. · Thrombosis Research · 25
Works count: 80
Citation count: 2,248
H-index: 25
I10-index: 41
Year
Topic
Type